Motley Fool Asset Management LLC Purchases 1,780 Shares of CME Group Inc. $CME

Motley Fool Asset Management LLC boosted its position in shares of CME Group Inc. (NASDAQ:CME) by 10.6% in the second quarter, Holdings Channel.com reports. The firm owned 18,542 shares of the financial services provider’s stock after acquiring an additional 1,780 shares during the period. Motley Fool Asset Management LLC’s holdings in CME Group were worth $5,111,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Webster Bank N. A. grew its holdings in shares of CME Group by 206.9% in the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 60 shares in the last quarter. Highline Wealth Partners LLC grew its holdings in shares of CME Group by 84.3% in the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 43 shares in the last quarter. Wayfinding Financial LLC bought a new position in shares of CME Group in the 1st quarter valued at about $25,000. Cornerstone Planning Group LLC grew its holdings in shares of CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 55 shares in the last quarter. Finally, Trifecta Capital Advisors LLC grew its holdings in shares of CME Group by 59.2% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock valued at $31,000 after acquiring an additional 42 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Trading Up 0.6%

Shares of NASDAQ:CME opened at $271.09 on Tuesday. The company has a 50-day simple moving average of $266.48 and a 200 day simple moving average of $272.02. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market capitalization of $97.70 billion, a P/E ratio of 26.27, a price-to-earnings-growth ratio of 6.65 and a beta of 0.41. CME Group Inc. has a 52-week low of $213.94 and a 52-week high of $290.79.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.63 by $0.05. The firm had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The business’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same period last year, the business posted $2.68 earnings per share. Sell-side analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were given a dividend of $1.25 per share. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 annualized dividend and a yield of 1.8%. CME Group’s dividend payout ratio (DPR) is 48.45%.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Keefe, Bruyette & Woods raised their price objective on CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a report on Monday, October 13th. Weiss Ratings reiterated a “buy (b)” rating on shares of CME Group in a research note on Wednesday, October 8th. Piper Sandler raised their target price on shares of CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research note on Tuesday, July 15th. UBS Group cut their target price on shares of CME Group from $285.00 to $280.00 and set a “neutral” rating for the company in a research note on Thursday. Finally, Wall Street Zen downgraded shares of CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, July 13th. Eight investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $284.53.

Insider Activity at CME Group

In other CME Group news, General Counsel Jonathan L. Marcus sold 392 shares of the firm’s stock in a transaction that occurred on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the sale, the general counsel directly owned 7,851 shares in the company, valued at $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Timothy Francis Mccourt sold 379 shares of the firm’s stock in a transaction that occurred on Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total transaction of $98,475.57. Following the sale, the insider owned 9,508 shares of the company’s stock, valued at $2,470,463.64. This trade represents a 3.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 13,043 shares of company stock valued at $3,527,956. 0.30% of the stock is currently owned by insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.